AGN — Argenica Therapeutics Share News
0.000.00%
Last trade - 00:00- AU$14.13m
- AU$9.09m
- AU$0.51m
Australia Stock Exchange release from ARGENICA THERAPE : Quarterly Activities/Appendix 4C Cash Flow Report
Australia Stock Exchange release from ARGENICA THERAPE : PRE_NR Ends: 08:24:35
Australia Stock Exchange release from ARGENICA THERAPE : Preliminary Pre-Clinical Tox Studies Successfully Completed
Australia Stock Exchange release from ARGENICA THERAPE : PRE_NR Ends: 08:26:52
Australia Stock Exchange release from ARGENICA THERAPE : Argenica Appoints Head of Clinical Development
Australia Stock Exchange release from ARGENICA THERAPE : Notification regarding unquoted securities - AGN
Australia Stock Exchange release from ARGENICA THERAPE : Application for quotation of securities - AGN
Australia Stock Exchange release from ARGENICA THERAPE : Release of Restricted Securities from Escrow
Australia's Argenica Therapeutics scales record high on U.S. patent grant
Australia Stock Exchange release from ARGENICA THERAPE : Argenica to be Granted Patent Protection in the US
Australia Stock Exchange release from ARGENICA THERAPE : PRE_NR Ends: 09:26:18
Australia Stock Exchange release from ARGENICA THERAPE : Results of Annual General Meeting
Australia Stock Exchange release from ARGENICA THERAPE : AGM Presentation
Australia Stock Exchange release from ARGENICA THERAPE : Positive Preclinical Data for ARG-007 Neuroprotection in HIE
Australia Stock Exchange release from ARGENICA THERAPE : PRE_NR Ends: 08:25:54
Australia Stock Exchange release from ARGENICA THERAPE : Quarterly Activities/Appendix 4C Cash Flow Report
Australia Stock Exchange release from ARGENICA THERAPE : PRE_NR Ends: 08:22:15
Australia Stock Exchange release from ARGENICA THERAPE : Investor Presentation
Australia Stock Exchange release from ARGENICA THERAPE : Phase 1 Clinical Trial Overview & Roadmap